The Head & Neck Cancer multidisciplinary teams are playing an increasing role in the management of head & neck malignancies. These teams have a great potential to improve the patient care and the healthcare system, however, they are faced with many challenges. The multidisciplinary approach has become very crucial recently due to the ever-increasing complexity of medical knowledge and the huge wealth of information that is available to physicians, in addition to the complexity of the various medical procedures and interventions available for cancer care. The multidisciplinary tumor board plays a critical role in the whole spectrum of cancer management, including diagnosis, staging, treatment and palliative care.
Medical Oncologists, Radiation Oncologists, Otolaryngologists, Surgeons, Radiologists, Hematologists, Pathologists, Plastic Surgeons and Oral and Maxillofacial Surgeons.
Implement an optimal course of treatment for head and neck cancer patients.
Utilize multiple approaches to diagnosis and treatment, including radiological findings.
Determine cancer staging using various imaging modalities for head and neck tumors.
Promote an interdisciplinary team approach by bridging gaps across the continuum of care in order to enhance the overall quality of patient-centered head and neck cancer care.
Implement strategies to address the challenges that viral infections have in the development of tumors of the head and neck.
Tumor Board meets weekly on Wednesday
FACULTY & DISCLOSURES:
Andre Abitbol, M.D., and Michael Troner, M.D.
Baptist Health Medical Group Oncology
Andre Abitbol, M.D., and Michael Troner, M.D. have indicated that they have no relevant financial relationships to disclose and the discussions will not include mention of investigational or off-label usage. The core group of contributors has provided disclosures; complete disclosure statements will be included on the sign-in sheet for this activity.